Quality control

SKYFALL
SKYFALLSKYFALL
QUALITY CONTROL
Amal George
SBS MGU
george.oa.jr@gmail.com
Quality Control - QC refers to the measures that must be included
during each assay run to verify that the test is working properly.
Quality Assurance - QA is defined as the overall program that ensures
that the final results reported by the laboratory are correct.
“The aim of quality control is simply to ensure that the results
generated by the test are correct. However, quality assurance is
concerned with much more: that the right test is carried out on the
right specimen, and that the right result and right interpretation is
delivered to the right person at the right time”
DEFINITIONS
Quality
The Degree to which a set of inherent characters fulfils the
requirements.
IMPORTANT TERMINOLOGIES
Precision
Precision is the reproducibility of an analytical method
Accuracy
Accuracy defines how close the measured value is to the actual value.
Sensitivity
Sensitivity of an assay in a measure of how little of the analyte the
method can detect.
Specificity
Specificity of a assay related to how good the assay is at discriminating
between the requested analyte and potentially interfering substances.
Standard
This is a substance of constant composition of sufficient purity to be
used for comparison purposes or standardisation
Control
This is a sample, which is chemically and Physically similar to
unknown specimen
A solution , lyophilised preparation or pool of collected human or
animal specimen or artificially derived material intend for use in the QC
process.
Calibrator:
A material or solution of
known concentration (or
activity / intensity) used to
calibrate or adjust a
measurement procedure. It is
also used to calculate the
concentration of an unknown
sample (as standard)
Variation in results
Biochemical measurements vary for two reasons, namely:
analytical variation
biological variation.
Quality Control
Analytical Measurement
Instrument not calibrated correctly
Specimens mix – up
Incorrect volume of specimen
Interfering substances present
Instrument precision problem
Test reporting
Wrong patient ID
Transcription error
Report not legible
Report delayed
ANALYTICAL ERRORS
POST ANALYTICAL ERRORS
Test interpretation
Interfering substance not recognized
Specificity of the test not understood
Precision limitation not recognized
Analytical sensitivity not appropriate
Previous values not available for
comparison
HOW TO CONTROL THESE ERRORS?
PRE ANALYTICAL VARIABLES
It is very difficult to establish effective methods for monitoring and
controlling preanalytical variables because many of the variables are
outside the laboratory areas.
Requires the coordinated effort of many individuals and hospital
departments
Patient Identification
The highest frequency of errors occurs with the use of handwritten labels
and request forms. The use of bar code technology has significantly
reduced ID problems.
Turn around time
Delayed and lost test requisitions, specimens and reports can be major
problems for labs. Recording of the actual times of specimen collection,
receipt in the lab and reporting of results with use of computers will
solve these problems.
Transcription error
A substantial risk of transcription error exists from manual entry of data even
with the double checking of results, computerization will reduce this type of
transcription error.
Patient preparation
Lab tests are affected by many factors, such as,
recent intake of food, alcohol, or drugs
smoking
exercise
stress
sleep
posture during specimen collection
The lab must define the instructions and procedures compliance with these
instructions can be monitored directly efforts should be made to correct non
compliance
GENERAL PRINCIPLES OF CONTROL CHARTS
 Control charts are simple graphical displays in which the
observed values are plotted versus the time when the observations
are made.
 The control limits are calculated from the mean (x) and
standard deviations (s)
Internal Quality Control Program for
Serological Testing
An internal quality control program depend on the use of internal
quality control (IQC) specimens, Shewhart Control Charts, and the use
of statistical methods for interpretation.
Internal Quality Control Specimens
IQC specimens comprises either (1) in-house patient sera (single or
pooled clinical samples), or (2) international serum standards with
values within each clinically significant ranges.
QC Log with Patient Results
Basic statistics to develop an acceptable control
range
The most fundamental statistics used by the laboratory are the mean [x] and
standard deviation [s].
Calculating a Mean [x]:
The mean (or average) is the laboratory’s best estimate of the analyte’s true
value for a specific level of control.
Calculating a Standard Deviation [s]:
 Standard deviation is a statistic that quantifies how close numerical values
(i.e., QC values) are in relation to each other
 Standard deviation is calculated for control products from the same data
used to calculate the mean.
 It provides the laboratory an estimate of test consistency at specific
concentrations.
 The repeatability of a test may be consistent (low standard deviation, low
imprecision) or inconsistent (high standard deviation, high imprecision).
Mean [x] Standard Deviation [s]
Creating a Levey-Jennings Chart
• Standard deviation is commonly used for preparing Levey-Jennings (L-J or LJ) charts.
The Levey-Jennings chart is used to graph successive (run-to-run or day-to-day)
quality control values.
• A chart is created for each test and level of control.
• The first step is to calculate decision limits. These limits are ±1s, ±2s and ±3s from
the mean.
• From the mean and standard deviation value calculated in the previous slide we can
now construct the Levy Jennings chart as follows:
The Levey-Jennings chart that was developed can be overlaid onto a bell-shaped curve to illustrate the
overall distribution of quality control values
Cont..
• When an analytical process is within control, approximately 68% of all
QC values fall within ±1 standard deviation (1s).
• Likewise 95.5% of all QC values fall within ±2 standard deviations (2s)
of the mean. About 4.5% of all data will be outside the ±2s limits
when the analytical process is in control. Approximately 99.7% of all
QC values are found to be within ±3 standard deviations (3s) of the
mean.
• As only 0.3%, or 3 out of 1000 points, will fall outside the ±3s limits,
any value outside of ±3s is considered to be associated with a
significant error condition and patient results should not be reported.
Systematic Errors
Trends: A trend indicates a gradual loss of reliability in the test system. Trends are usually subtle. Causes of
trending may include:
Systematic error is evidenced by a change in the mean of the control values. The change in the mean may be gradual
and demonstrated as a trend in control values or it may be abrupt and demonstrated as a shift in control values.
 Deterioration of the instrument light source
 Gradual accumulation of debris in sample/reagent tubing
 Gradual accumulation of debris on electrode surfaces
 Aging of reagents
 Gradual deterioration of control materials
 Gradual deterioration of incubation chamber
 temperature (enzymes only)
 Gradual deterioration of light filter integrity
 Gradual deterioration of calibration
Shift
Abrupt changes in the control mean are defined as shifts. Shifts in QC data represent a
sudden and dramatic positive or negative change in test system performance. Shifts
may be caused by:
 Sudden failure or change in the light source
 Change in reagent formulation
 Change of reagent lot
 Major instrument maintenance
 Sudden change in incubation temperature (enzymes
only)
 Change in room temperature or humidity
 Failure in the sampling system
 Failure in reagent dispense system
 Inaccurate calibration/recalibration
Random Errors
 Random error is any deviation away from an expected
result.
 For QC results, any positive or negative deviation away from
the calculated mean is defined as random error.
 There is acceptable (or expected) random error as defined
and quantified by standard deviation.
 There is unacceptable (unexpected) random error that is
any data point outside the expected population of data
(e.g., a data point outside the ±3s limits).
Westgard Rules
There are six basic rules in the Westgard scheme.
These rules are used individually or in combination to evaluate the quality
of analytical runs.
Most of the quality control rules can be expressed as NL where N
represents the number of control observations to be evaluated and L
represents the statistical limit for evaluating the control observations
Thus 13s represents a control rule that is violated when one control
observation exceeds the ±3s control limits.
Rule 12s
This rule merely warns that random error
or systematic error may be present in the
test system
The relationship between this value and
other control results within the current
and previous analytical runs must be
examined. If no relationship can be found
and no source of error can be identified,
it must be assumed that a single control
value outside the ±2s limits is an
acceptable random error.
Rule 13s
This rule identifies unacceptable
random error or possibly the
beginning of a large systematic
error. Any QC result outside ±3s
violates this rule.
Rule 22s
This rule identifies systematic error only. The criteria for
violation of this rule are:
• Two consecutive QC results
• Greater than 2s
• On the same side of the mean
There are two applications to this rule: within-run and across runs. The
within-run application affects all control results obtained for the current
analytical run.
• If a normal (Level I) and abnormal (Level II) control are assayed in this
run and both levels of control are greater than 2s on the same side of
the mean, this run violates the within-run application for systematic
error. If however, Level I is -1s and Level II is +2.5s (a violation of the 12s
rule), the Level II result from the previous run must be examined. If
Level II in the previous run was at +2.0s or greater, then the across run
application for systematic error is violated.
Violation of the within-run application indicates that systematic error is
present and that it affects potentially the entire analytical curve.
Violation of the across run application indicates that only a single
portion of the analytical curve is affected by the error.
• This rule identifies random error only,
and is applied only within the current
run. If there is at least a 4s difference
between control values within a single
run, the rule is violated for random
error.
• For example, assume both Level I and
Level II have been assayed within the
current run. Level I is +2.8s above the
mean and Level II is -1.3s below the
mean. The total difference between the
two control levels is greater than 4s
(e.g. [+2.8s – (-1.3s)] = 4.1s).
Rule R4s
The criteria which must be met to violate this rule are:
• Three consecutive results
• Greater than 1s
• On the same side of the mean
Rule 31s
The criteria which must be met to violate this rule are:
• Four consecutive results
• Greater than 1s
• On the same side of the mean
Rule 41s
There are two applications to the 31s and 41s rule. These are within control material (e.g. all Level I
control results) or across control materials (e.g., Level I, II, and III control results in combination).
Within control material violations indicate systematic bias in a single area of the method curve while
violation of the across control materials application indicates systematic error over a broader
concentration
Rules 7X 8X 9X 10X12X
These rules are violated when there are: 7 or
8, or 9, or 10, or 12 control results On the
same side of the mean regardless of the
specific standard deviation in which they are
located.
Each of these rules also has two applications:
within control material (e.g., all Level I
control results) or across control materials
(e.g. Level I, II, and III control results in
combination).
Within control material violations indicate
systematic bias in a single area of the method
curve while violation of the across control
materials application indicates systematic
bias over a broader concentration
Coefficient of Variation [CV]
• The Coefficient of Variation [CV] is the ratio of the standard deviation to the mean and is expressed as a
percentage.
• CV allows the technologist to make easier comparisons of the overall precision.
• Standard deviation typically increases as the concentration of the analyte increases, the CV can be regarded
as a statistical equalizer.
• Technologist/technician who is comparing precision for two different methods and uses only standard
deviation, can be easily misled
• For example, a comparison between hexokinase and glucose oxidase (two methods for assaying glucose) is
required. The standard deviation for the hexokinase method is 4.8 and it is 4.0 for glucose oxidase. If the
comparison only uses standard deviation, it can be incorrectly assumed that the glucose oxidase method is
more precise that the hexokinase method. If, however, a CV is calculated, it might show that both methods
are equally precise. Assume the mean for the hexokinase method is 120 and the glucose oxidase mean is
100. The CV then, for both methods, is 4%. They are equally precise.
Coefficient of Variation Ratio [CVR]
• Accuracy of test results is paramount in the clinical laboratory, precision is just as
important
• One way a laboratory can determine whether the precision of a specific test is
acceptable is to compare its precision to that of another laboratory performing the same
test on the same instrument using the same reagents (laboratory peer group)
• If the CV for potassium on a particular instrument is 4% and the potassium for all other
laboratories using the same instrument is 4.2%, then the coefficient of variation ratio
[CVR] is 4/4.2 or 0.95.
• Any ratio less than 1.0 indicates that precision is better than the peer group. Any score
greater than 1.0 indicates that imprecision is larger
• Ratios greater than 1.5 indicate a need to investigate the cause of imprecision and any
ratio of 2.0 or greater usually indicates need for troubleshooting and corrective action
Standard Deviation Index [SDI]
• The standard deviation index [SDI] is a peer-based estimate of reliability. If the peer group mean is
defined as XGroup , the standard deviation is defined as SGroup and the laboratory’s mean is
defined as Xlab
• The target SDI is 0.0 which indicates a perfect comparison with the peer group. The following
guidelines may be used with SDI. A value of:
• 1.25 or less is considered acceptable.
• 1.25 – 1.49 is considered acceptable to marginal performance. Some investigation of
• the test system may be required.
• 1.5 – 1.99 is considered marginal performance and investigation of the test system is
• recommended.
• 2.0 or greater is generally considered to be unacceptable performance and remedial action is
usually required.
Thankyou!
1 sur 33

Recommandé

Quality Control in Laboratory par
Quality Control in LaboratoryQuality Control in Laboratory
Quality Control in LaboratoryManal Elsayed CPPS, CPHQ, CLSSBB, FISQua, DTQM
62.8K vues22 diapositives
Quality Control in a Medical Testing Laboratory par
Quality Control in a Medical Testing LaboratoryQuality Control in a Medical Testing Laboratory
Quality Control in a Medical Testing LaboratoryDr. Bikash Kumar Chaudhury
46.5K vues63 diapositives
Quality control in the medical laboratory par
Quality control in the medical laboratoryQuality control in the medical laboratory
Quality control in the medical laboratoryAdnan Jaran
40.3K vues33 diapositives
Quality Control par
Quality ControlQuality Control
Quality ControlDr. Aryan (Anish Dhakal)
16.9K vues25 diapositives
WESTGARD RULES par
WESTGARD RULESWESTGARD RULES
WESTGARD RULESDr. K. Selvakumar @ Benny
41.2K vues31 diapositives
Quality control par
Quality controlQuality control
Quality controlPavalaveelzi C.M
12.2K vues82 diapositives

Contenu connexe

Tendances

Total Quality Management in Medical Laboratories par
Total Quality Management in Medical LaboratoriesTotal Quality Management in Medical Laboratories
Total Quality Management in Medical LaboratoriesCHRISTIAN MEDICAL COLLEGE AND HOSPITAL
7.2K vues43 diapositives
Quality control in clinical laboratory par
Quality control in clinical laboratoryQuality control in clinical laboratory
Quality control in clinical laboratorydrgomi basar
180.5K vues98 diapositives
Laboratory Internal Quality Control presentation master revision, 2014 par
Laboratory Internal Quality Control presentation master revision, 2014Laboratory Internal Quality Control presentation master revision, 2014
Laboratory Internal Quality Control presentation master revision, 2014Adel Elazab Elged
21.1K vues40 diapositives
Internal quality control par
Internal quality controlInternal quality control
Internal quality controlSyed Basheer
7.2K vues31 diapositives
Quality Control In Clinical Laboratory par
Quality Control In Clinical LaboratoryQuality Control In Clinical Laboratory
Quality Control In Clinical LaboratoryDr. Rajesh Bendre
5K vues37 diapositives
Quality control in clinical biochemistry par
Quality control in clinical biochemistryQuality control in clinical biochemistry
Quality control in clinical biochemistryAshok Katta
68.4K vues62 diapositives

Tendances(20)

Quality control in clinical laboratory par drgomi basar
Quality control in clinical laboratoryQuality control in clinical laboratory
Quality control in clinical laboratory
drgomi basar180.5K vues
Laboratory Internal Quality Control presentation master revision, 2014 par Adel Elazab Elged
Laboratory Internal Quality Control presentation master revision, 2014Laboratory Internal Quality Control presentation master revision, 2014
Laboratory Internal Quality Control presentation master revision, 2014
Adel Elazab Elged21.1K vues
Internal quality control par Syed Basheer
Internal quality controlInternal quality control
Internal quality control
Syed Basheer7.2K vues
Quality control in clinical biochemistry par Ashok Katta
Quality control in clinical biochemistryQuality control in clinical biochemistry
Quality control in clinical biochemistry
Ashok Katta68.4K vues
Haemoglobin quality control by maintaining levey jennings chart par Dr Rashmi Sood
Haemoglobin quality control by maintaining levey jennings chartHaemoglobin quality control by maintaining levey jennings chart
Haemoglobin quality control by maintaining levey jennings chart
Dr Rashmi Sood6.4K vues
Laboratory accreditation par Gift Sam
Laboratory accreditationLaboratory accreditation
Laboratory accreditation
Gift Sam18.5K vues
External Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ... par Adel Elazab Elged
External Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...External Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...
External Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...
Adel Elazab Elged6.1K vues
Quality assurance in the department of clinical biochemistry par Dipesh Tamrakar
Quality assurance in the department of clinical biochemistryQuality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistry
Dipesh Tamrakar7.2K vues
Pre analytic and postanalytic test management par Varsha Shahane
Pre analytic and postanalytic test managementPre analytic and postanalytic test management
Pre analytic and postanalytic test management
Varsha Shahane19.2K vues
Basics of laboratory internal quality control, Ola Elgaddar, 2012 par Ola Elgaddar
Basics of laboratory internal quality control, Ola Elgaddar, 2012Basics of laboratory internal quality control, Ola Elgaddar, 2012
Basics of laboratory internal quality control, Ola Elgaddar, 2012
Ola Elgaddar17.8K vues

Similaire à Quality control

Quality management system BY M .REJA par
Quality management system BY M .REJAQuality management system BY M .REJA
Quality management system BY M .REJAMamunReja1
127 vues49 diapositives
Laboratory Quality Control .ppt par
Laboratory Quality Control .pptLaboratory Quality Control .ppt
Laboratory Quality Control .pptABRARAHMED767665
761 vues45 diapositives
Quality control.pptx par
Quality control.pptxQuality control.pptx
Quality control.pptxaditisikarwar2
7 vues74 diapositives
Clinical lab qc sethu par
Clinical lab qc sethuClinical lab qc sethu
Clinical lab qc sethusubramaniam sethupathy
850 vues76 diapositives
Qc and qa par
Qc and qaQc and qa
Qc and qaZahid Chughtai
71 vues21 diapositives
Quality assurance and quality control par
Quality assurance and quality controlQuality assurance and quality control
Quality assurance and quality controlECRD2015
385 vues8 diapositives

Similaire à Quality control(20)

Quality management system BY M .REJA par MamunReja1
Quality management system BY M .REJAQuality management system BY M .REJA
Quality management system BY M .REJA
MamunReja1127 vues
Quality assurance and quality control par ECRD2015
Quality assurance and quality controlQuality assurance and quality control
Quality assurance and quality control
ECRD2015385 vues
Chapter 12 par ECRD IN
Chapter 12Chapter 12
Chapter 12
ECRD IN38 vues
Quality Assurance and Quality Control par ECRD IN
Quality Assurance and Quality ControlQuality Assurance and Quality Control
Quality Assurance and Quality Control
ECRD IN218 vues
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro... par Randox
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Randox2.9K vues
Control of analytical quality using stable control materials postgrad par MedhatEldeeb2
Control of analytical quality using stable control materials postgradControl of analytical quality using stable control materials postgrad
Control of analytical quality using stable control materials postgrad
MedhatEldeeb2256 vues
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan) par Aamir Ijaz Brig
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Aamir Ijaz Brig875 vues
quality control in clinical laboratory par DrmanarEmam
quality control in clinical laboratory quality control in clinical laboratory
quality control in clinical laboratory
DrmanarEmam171 vues
Variability of clinical chemistry laboratory results par AdetokunboAjala
Variability of clinical  chemistry laboratory resultsVariability of clinical  chemistry laboratory results
Variability of clinical chemistry laboratory results
AdetokunboAjala292 vues
Internal quality control in blood bank testing par Sanjeew Yadav
Internal quality control in blood bank testingInternal quality control in blood bank testing
Internal quality control in blood bank testing
Sanjeew Yadav17.7K vues
2. Quality Control Notes par Leah Molai
2. Quality Control Notes2. Quality Control Notes
2. Quality Control Notes
Leah Molai627 vues
Basics of quality assurance laboratory services par AhmadAlnatour5
Basics of quality assurance laboratory servicesBasics of quality assurance laboratory services
Basics of quality assurance laboratory services
AhmadAlnatour5221 vues

Plus de SKYFALL

Structure of amino acids par
Structure of amino acidsStructure of amino acids
Structure of amino acidsSKYFALL
5.8K vues13 diapositives
ALL ABOUT VITAMINS VITAMIN B6, B7, B12 AND FOLIC ACID par
ALL ABOUT VITAMINS VITAMIN B6, B7, B12 AND FOLIC ACIDALL ABOUT VITAMINS VITAMIN B6, B7, B12 AND FOLIC ACID
ALL ABOUT VITAMINS VITAMIN B6, B7, B12 AND FOLIC ACIDSKYFALL
3.7K vues60 diapositives
Bacteriophages par
Bacteriophages  Bacteriophages
Bacteriophages SKYFALL
17.5K vues31 diapositives
Nutrition in pregnancy and lactation par
Nutrition in pregnancy and lactation Nutrition in pregnancy and lactation
Nutrition in pregnancy and lactation SKYFALL
13.1K vues18 diapositives
RIA, IMMUNOFLURESCENCE ASSAY par
RIA, IMMUNOFLURESCENCE ASSAYRIA, IMMUNOFLURESCENCE ASSAY
RIA, IMMUNOFLURESCENCE ASSAYSKYFALL
10.9K vues20 diapositives
GLP par
GLPGLP
GLPSKYFALL
2.1K vues18 diapositives

Plus de SKYFALL(15)

Structure of amino acids par SKYFALL
Structure of amino acidsStructure of amino acids
Structure of amino acids
SKYFALL5.8K vues
ALL ABOUT VITAMINS VITAMIN B6, B7, B12 AND FOLIC ACID par SKYFALL
ALL ABOUT VITAMINS VITAMIN B6, B7, B12 AND FOLIC ACIDALL ABOUT VITAMINS VITAMIN B6, B7, B12 AND FOLIC ACID
ALL ABOUT VITAMINS VITAMIN B6, B7, B12 AND FOLIC ACID
SKYFALL3.7K vues
Bacteriophages par SKYFALL
Bacteriophages  Bacteriophages
Bacteriophages
SKYFALL17.5K vues
Nutrition in pregnancy and lactation par SKYFALL
Nutrition in pregnancy and lactation Nutrition in pregnancy and lactation
Nutrition in pregnancy and lactation
SKYFALL13.1K vues
RIA, IMMUNOFLURESCENCE ASSAY par SKYFALL
RIA, IMMUNOFLURESCENCE ASSAYRIA, IMMUNOFLURESCENCE ASSAY
RIA, IMMUNOFLURESCENCE ASSAY
SKYFALL10.9K vues
GLP par SKYFALL
GLPGLP
GLP
SKYFALL2.1K vues
Structural aberrations of chromosomes par SKYFALL
Structural aberrations of chromosomesStructural aberrations of chromosomes
Structural aberrations of chromosomes
SKYFALL49.2K vues
The citric acid cycle par SKYFALL
The citric acid cycleThe citric acid cycle
The citric acid cycle
SKYFALL8.1K vues
Trp operon par SKYFALL
Trp operonTrp operon
Trp operon
SKYFALL54.5K vues
Regulation of glycolysis and gluconeogenesis par SKYFALL
Regulation of glycolysis and gluconeogenesisRegulation of glycolysis and gluconeogenesis
Regulation of glycolysis and gluconeogenesis
SKYFALL14.3K vues
Rna pol ii par SKYFALL
Rna pol iiRna pol ii
Rna pol ii
SKYFALL775 vues
Complement fixation par SKYFALL
Complement fixationComplement fixation
Complement fixation
SKYFALL8K vues
Cerebrospinal fluid par SKYFALL
Cerebrospinal fluidCerebrospinal fluid
Cerebrospinal fluid
SKYFALL5.8K vues
Density gradient centrifugation par SKYFALL
Density gradient centrifugationDensity gradient centrifugation
Density gradient centrifugation
SKYFALL66.1K vues
Thyroid hormone disorders par SKYFALL
Thyroid hormone disordersThyroid hormone disorders
Thyroid hormone disorders
SKYFALL1.4K vues

Dernier

Women in the Workplace Industry Insights for Life Sciences par
Women in the Workplace Industry Insights for Life SciencesWomen in the Workplace Industry Insights for Life Sciences
Women in the Workplace Industry Insights for Life Sciencesworkplacesurvey
5 vues27 diapositives
Class 2 (12 july).pdf par
  Class 2 (12 july).pdf  Class 2 (12 july).pdf
Class 2 (12 july).pdfclimber9977
8 vues1 diapositive
Max Welling ChemAI 231116.pptx par
Max Welling ChemAI 231116.pptxMax Welling ChemAI 231116.pptx
Max Welling ChemAI 231116.pptxMarco Tibaldi
132 vues35 diapositives
Synthesis and Characterization of Magnetite-Magnesium Sulphate-Sodium Dodecyl... par
Synthesis and Characterization of Magnetite-Magnesium Sulphate-Sodium Dodecyl...Synthesis and Characterization of Magnetite-Magnesium Sulphate-Sodium Dodecyl...
Synthesis and Characterization of Magnetite-Magnesium Sulphate-Sodium Dodecyl...GIFT KIISI NKIN
12 vues31 diapositives
MSC III_Advance Forensic Serology_Final.pptx par
MSC III_Advance Forensic Serology_Final.pptxMSC III_Advance Forensic Serology_Final.pptx
MSC III_Advance Forensic Serology_Final.pptxSuchita Rawat
10 vues109 diapositives
1978 NASA News Release Log par
1978 NASA News Release Log1978 NASA News Release Log
1978 NASA News Release Logpurrterminator
7 vues146 diapositives

Dernier(20)

Women in the Workplace Industry Insights for Life Sciences par workplacesurvey
Women in the Workplace Industry Insights for Life SciencesWomen in the Workplace Industry Insights for Life Sciences
Women in the Workplace Industry Insights for Life Sciences
Max Welling ChemAI 231116.pptx par Marco Tibaldi
Max Welling ChemAI 231116.pptxMax Welling ChemAI 231116.pptx
Max Welling ChemAI 231116.pptx
Marco Tibaldi132 vues
Synthesis and Characterization of Magnetite-Magnesium Sulphate-Sodium Dodecyl... par GIFT KIISI NKIN
Synthesis and Characterization of Magnetite-Magnesium Sulphate-Sodium Dodecyl...Synthesis and Characterization of Magnetite-Magnesium Sulphate-Sodium Dodecyl...
Synthesis and Characterization of Magnetite-Magnesium Sulphate-Sodium Dodecyl...
GIFT KIISI NKIN12 vues
MSC III_Advance Forensic Serology_Final.pptx par Suchita Rawat
MSC III_Advance Forensic Serology_Final.pptxMSC III_Advance Forensic Serology_Final.pptx
MSC III_Advance Forensic Serology_Final.pptx
Suchita Rawat10 vues
Open Access Publishing in Astrophysics par Peter Coles
Open Access Publishing in AstrophysicsOpen Access Publishing in Astrophysics
Open Access Publishing in Astrophysics
Peter Coles380 vues
Physical Characterization of Moon Impactor WE0913A par Sérgio Sacani
Physical Characterization of Moon Impactor WE0913APhysical Characterization of Moon Impactor WE0913A
Physical Characterization of Moon Impactor WE0913A
Sérgio Sacani42 vues
Distinct distributions of elliptical and disk galaxies across the Local Super... par Sérgio Sacani
Distinct distributions of elliptical and disk galaxies across the Local Super...Distinct distributions of elliptical and disk galaxies across the Local Super...
Distinct distributions of elliptical and disk galaxies across the Local Super...
Sérgio Sacani30 vues
Ethical issues associated with Genetically Modified Crops and Genetically Mod... par PunithKumars6
Ethical issues associated with Genetically Modified Crops and Genetically Mod...Ethical issues associated with Genetically Modified Crops and Genetically Mod...
Ethical issues associated with Genetically Modified Crops and Genetically Mod...
PunithKumars618 vues
Workshop LLM Life Sciences ChemAI 231116.pptx par Marco Tibaldi
Workshop LLM Life Sciences ChemAI 231116.pptxWorkshop LLM Life Sciences ChemAI 231116.pptx
Workshop LLM Life Sciences ChemAI 231116.pptx
Marco Tibaldi96 vues
himalay baruah acid fast staining.pptx par HimalayBaruah
himalay baruah acid fast staining.pptxhimalay baruah acid fast staining.pptx
himalay baruah acid fast staining.pptx
HimalayBaruah5 vues
How to be(come) a successful PhD student par Tom Mens
How to be(come) a successful PhD studentHow to be(come) a successful PhD student
How to be(come) a successful PhD student
Tom Mens374 vues
EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF SALIX SUBSERRATA IN PARACETAMOL IN... par gynomark
EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF SALIX SUBSERRATA IN PARACETAMOL IN...EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF SALIX SUBSERRATA IN PARACETAMOL IN...
EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF SALIX SUBSERRATA IN PARACETAMOL IN...
gynomark9 vues
Artificial Intelligence Helps in Drug Designing and Discovery.pptx par abhinashsahoo2001
Artificial Intelligence Helps in Drug Designing and Discovery.pptxArtificial Intelligence Helps in Drug Designing and Discovery.pptx
Artificial Intelligence Helps in Drug Designing and Discovery.pptx

Quality control

  • 1. QUALITY CONTROL Amal George SBS MGU george.oa.jr@gmail.com
  • 2. Quality Control - QC refers to the measures that must be included during each assay run to verify that the test is working properly. Quality Assurance - QA is defined as the overall program that ensures that the final results reported by the laboratory are correct. “The aim of quality control is simply to ensure that the results generated by the test are correct. However, quality assurance is concerned with much more: that the right test is carried out on the right specimen, and that the right result and right interpretation is delivered to the right person at the right time” DEFINITIONS
  • 3. Quality The Degree to which a set of inherent characters fulfils the requirements. IMPORTANT TERMINOLOGIES
  • 4. Precision Precision is the reproducibility of an analytical method Accuracy Accuracy defines how close the measured value is to the actual value.
  • 5. Sensitivity Sensitivity of an assay in a measure of how little of the analyte the method can detect. Specificity Specificity of a assay related to how good the assay is at discriminating between the requested analyte and potentially interfering substances.
  • 6. Standard This is a substance of constant composition of sufficient purity to be used for comparison purposes or standardisation Control This is a sample, which is chemically and Physically similar to unknown specimen A solution , lyophilised preparation or pool of collected human or animal specimen or artificially derived material intend for use in the QC process.
  • 7. Calibrator: A material or solution of known concentration (or activity / intensity) used to calibrate or adjust a measurement procedure. It is also used to calculate the concentration of an unknown sample (as standard)
  • 8. Variation in results Biochemical measurements vary for two reasons, namely: analytical variation biological variation. Quality Control
  • 9. Analytical Measurement Instrument not calibrated correctly Specimens mix – up Incorrect volume of specimen Interfering substances present Instrument precision problem Test reporting Wrong patient ID Transcription error Report not legible Report delayed ANALYTICAL ERRORS
  • 10. POST ANALYTICAL ERRORS Test interpretation Interfering substance not recognized Specificity of the test not understood Precision limitation not recognized Analytical sensitivity not appropriate Previous values not available for comparison
  • 11. HOW TO CONTROL THESE ERRORS? PRE ANALYTICAL VARIABLES It is very difficult to establish effective methods for monitoring and controlling preanalytical variables because many of the variables are outside the laboratory areas. Requires the coordinated effort of many individuals and hospital departments Patient Identification The highest frequency of errors occurs with the use of handwritten labels and request forms. The use of bar code technology has significantly reduced ID problems. Turn around time Delayed and lost test requisitions, specimens and reports can be major problems for labs. Recording of the actual times of specimen collection, receipt in the lab and reporting of results with use of computers will solve these problems.
  • 12. Transcription error A substantial risk of transcription error exists from manual entry of data even with the double checking of results, computerization will reduce this type of transcription error. Patient preparation Lab tests are affected by many factors, such as, recent intake of food, alcohol, or drugs smoking exercise stress sleep posture during specimen collection The lab must define the instructions and procedures compliance with these instructions can be monitored directly efforts should be made to correct non compliance
  • 13. GENERAL PRINCIPLES OF CONTROL CHARTS  Control charts are simple graphical displays in which the observed values are plotted versus the time when the observations are made.  The control limits are calculated from the mean (x) and standard deviations (s)
  • 14. Internal Quality Control Program for Serological Testing An internal quality control program depend on the use of internal quality control (IQC) specimens, Shewhart Control Charts, and the use of statistical methods for interpretation. Internal Quality Control Specimens IQC specimens comprises either (1) in-house patient sera (single or pooled clinical samples), or (2) international serum standards with values within each clinically significant ranges.
  • 15. QC Log with Patient Results
  • 16. Basic statistics to develop an acceptable control range The most fundamental statistics used by the laboratory are the mean [x] and standard deviation [s]. Calculating a Mean [x]: The mean (or average) is the laboratory’s best estimate of the analyte’s true value for a specific level of control. Calculating a Standard Deviation [s]:  Standard deviation is a statistic that quantifies how close numerical values (i.e., QC values) are in relation to each other  Standard deviation is calculated for control products from the same data used to calculate the mean.  It provides the laboratory an estimate of test consistency at specific concentrations.  The repeatability of a test may be consistent (low standard deviation, low imprecision) or inconsistent (high standard deviation, high imprecision).
  • 17. Mean [x] Standard Deviation [s]
  • 18. Creating a Levey-Jennings Chart • Standard deviation is commonly used for preparing Levey-Jennings (L-J or LJ) charts. The Levey-Jennings chart is used to graph successive (run-to-run or day-to-day) quality control values. • A chart is created for each test and level of control. • The first step is to calculate decision limits. These limits are ±1s, ±2s and ±3s from the mean. • From the mean and standard deviation value calculated in the previous slide we can now construct the Levy Jennings chart as follows:
  • 19. The Levey-Jennings chart that was developed can be overlaid onto a bell-shaped curve to illustrate the overall distribution of quality control values
  • 20. Cont.. • When an analytical process is within control, approximately 68% of all QC values fall within ±1 standard deviation (1s). • Likewise 95.5% of all QC values fall within ±2 standard deviations (2s) of the mean. About 4.5% of all data will be outside the ±2s limits when the analytical process is in control. Approximately 99.7% of all QC values are found to be within ±3 standard deviations (3s) of the mean. • As only 0.3%, or 3 out of 1000 points, will fall outside the ±3s limits, any value outside of ±3s is considered to be associated with a significant error condition and patient results should not be reported.
  • 21. Systematic Errors Trends: A trend indicates a gradual loss of reliability in the test system. Trends are usually subtle. Causes of trending may include: Systematic error is evidenced by a change in the mean of the control values. The change in the mean may be gradual and demonstrated as a trend in control values or it may be abrupt and demonstrated as a shift in control values.  Deterioration of the instrument light source  Gradual accumulation of debris in sample/reagent tubing  Gradual accumulation of debris on electrode surfaces  Aging of reagents  Gradual deterioration of control materials  Gradual deterioration of incubation chamber  temperature (enzymes only)  Gradual deterioration of light filter integrity  Gradual deterioration of calibration
  • 22. Shift Abrupt changes in the control mean are defined as shifts. Shifts in QC data represent a sudden and dramatic positive or negative change in test system performance. Shifts may be caused by:  Sudden failure or change in the light source  Change in reagent formulation  Change of reagent lot  Major instrument maintenance  Sudden change in incubation temperature (enzymes only)  Change in room temperature or humidity  Failure in the sampling system  Failure in reagent dispense system  Inaccurate calibration/recalibration
  • 23. Random Errors  Random error is any deviation away from an expected result.  For QC results, any positive or negative deviation away from the calculated mean is defined as random error.  There is acceptable (or expected) random error as defined and quantified by standard deviation.  There is unacceptable (unexpected) random error that is any data point outside the expected population of data (e.g., a data point outside the ±3s limits).
  • 24. Westgard Rules There are six basic rules in the Westgard scheme. These rules are used individually or in combination to evaluate the quality of analytical runs. Most of the quality control rules can be expressed as NL where N represents the number of control observations to be evaluated and L represents the statistical limit for evaluating the control observations Thus 13s represents a control rule that is violated when one control observation exceeds the ±3s control limits.
  • 25. Rule 12s This rule merely warns that random error or systematic error may be present in the test system The relationship between this value and other control results within the current and previous analytical runs must be examined. If no relationship can be found and no source of error can be identified, it must be assumed that a single control value outside the ±2s limits is an acceptable random error. Rule 13s This rule identifies unacceptable random error or possibly the beginning of a large systematic error. Any QC result outside ±3s violates this rule.
  • 26. Rule 22s This rule identifies systematic error only. The criteria for violation of this rule are: • Two consecutive QC results • Greater than 2s • On the same side of the mean There are two applications to this rule: within-run and across runs. The within-run application affects all control results obtained for the current analytical run. • If a normal (Level I) and abnormal (Level II) control are assayed in this run and both levels of control are greater than 2s on the same side of the mean, this run violates the within-run application for systematic error. If however, Level I is -1s and Level II is +2.5s (a violation of the 12s rule), the Level II result from the previous run must be examined. If Level II in the previous run was at +2.0s or greater, then the across run application for systematic error is violated. Violation of the within-run application indicates that systematic error is present and that it affects potentially the entire analytical curve. Violation of the across run application indicates that only a single portion of the analytical curve is affected by the error.
  • 27. • This rule identifies random error only, and is applied only within the current run. If there is at least a 4s difference between control values within a single run, the rule is violated for random error. • For example, assume both Level I and Level II have been assayed within the current run. Level I is +2.8s above the mean and Level II is -1.3s below the mean. The total difference between the two control levels is greater than 4s (e.g. [+2.8s – (-1.3s)] = 4.1s). Rule R4s
  • 28. The criteria which must be met to violate this rule are: • Three consecutive results • Greater than 1s • On the same side of the mean Rule 31s The criteria which must be met to violate this rule are: • Four consecutive results • Greater than 1s • On the same side of the mean Rule 41s There are two applications to the 31s and 41s rule. These are within control material (e.g. all Level I control results) or across control materials (e.g., Level I, II, and III control results in combination). Within control material violations indicate systematic bias in a single area of the method curve while violation of the across control materials application indicates systematic error over a broader concentration
  • 29. Rules 7X 8X 9X 10X12X These rules are violated when there are: 7 or 8, or 9, or 10, or 12 control results On the same side of the mean regardless of the specific standard deviation in which they are located. Each of these rules also has two applications: within control material (e.g., all Level I control results) or across control materials (e.g. Level I, II, and III control results in combination). Within control material violations indicate systematic bias in a single area of the method curve while violation of the across control materials application indicates systematic bias over a broader concentration
  • 30. Coefficient of Variation [CV] • The Coefficient of Variation [CV] is the ratio of the standard deviation to the mean and is expressed as a percentage. • CV allows the technologist to make easier comparisons of the overall precision. • Standard deviation typically increases as the concentration of the analyte increases, the CV can be regarded as a statistical equalizer. • Technologist/technician who is comparing precision for two different methods and uses only standard deviation, can be easily misled • For example, a comparison between hexokinase and glucose oxidase (two methods for assaying glucose) is required. The standard deviation for the hexokinase method is 4.8 and it is 4.0 for glucose oxidase. If the comparison only uses standard deviation, it can be incorrectly assumed that the glucose oxidase method is more precise that the hexokinase method. If, however, a CV is calculated, it might show that both methods are equally precise. Assume the mean for the hexokinase method is 120 and the glucose oxidase mean is 100. The CV then, for both methods, is 4%. They are equally precise.
  • 31. Coefficient of Variation Ratio [CVR] • Accuracy of test results is paramount in the clinical laboratory, precision is just as important • One way a laboratory can determine whether the precision of a specific test is acceptable is to compare its precision to that of another laboratory performing the same test on the same instrument using the same reagents (laboratory peer group) • If the CV for potassium on a particular instrument is 4% and the potassium for all other laboratories using the same instrument is 4.2%, then the coefficient of variation ratio [CVR] is 4/4.2 or 0.95. • Any ratio less than 1.0 indicates that precision is better than the peer group. Any score greater than 1.0 indicates that imprecision is larger • Ratios greater than 1.5 indicate a need to investigate the cause of imprecision and any ratio of 2.0 or greater usually indicates need for troubleshooting and corrective action
  • 32. Standard Deviation Index [SDI] • The standard deviation index [SDI] is a peer-based estimate of reliability. If the peer group mean is defined as XGroup , the standard deviation is defined as SGroup and the laboratory’s mean is defined as Xlab • The target SDI is 0.0 which indicates a perfect comparison with the peer group. The following guidelines may be used with SDI. A value of: • 1.25 or less is considered acceptable. • 1.25 – 1.49 is considered acceptable to marginal performance. Some investigation of • the test system may be required. • 1.5 – 1.99 is considered marginal performance and investigation of the test system is • recommended. • 2.0 or greater is generally considered to be unacceptable performance and remedial action is usually required.